Uvax Bio Appoints CBO Kevin O’Neill as Interim CEO Amid Strategic Transition 1 year ago AnaIn Pharma Industry UpdatesResearch Updates
Novartis Accelerates Stroke Prevention Strategy with $3.1B Acquisition of Anthos 1 year ago AnaIn DealsLeadersResearch Updates
India Poised to Become Key Hub for Early-Stage Clinical Trials: Parexel’s Strategic Expansion 1 year ago AnaIn BreakthroughsTop Stories
FDA Approves First Oral Therapy for Severe Eczema in Adolescents 1 year ago AnaIn Biopharma HighlightsBreaking NewsFDA ApprovalsLeaders
J&J Pulls the Plug on Alzheimer’s Seltorexant and Other Neuroscience Programs 1 year ago AnaIn Pharma Industry UpdatesTop Stories
Vertex Wins FDA Approval for JOURNAVX™, the First Non-Opioid Oral Pain Signal Inhibitor in Over 20 Years 1 year ago AnaIn Breaking NewsBreakthroughsFDA ApprovalsTop Stories
Funding Surge Fuels Innovation: Verdiva, Aviceda, Windward, and Colossal Secure Big Series Rounds in January 1 year ago AnaIn Biopharma HighlightsBreakthroughsDealsFunding RoundsLeadersVenture Capital
Atalanta Therapeutics Secures $97M Series B to Advance RNAi Treatments for Epilepsy and Huntington’s Disease 1 year ago AnaIn Clinical TrialsInvestmentsPartnershipsResearch UpdatesVenture Capital
Allakos Collapses After Failed Trial in Chronic Hives, Slashing Workforce by 75% 1 year ago AnaIn Clinical TrialsDealsResearch UpdatesStartupsTop Stories
Sarepta’s Gene Therapy Elevidys Shows Positive Phase III Results in Duchenne Muscular Dystrophy 1 year ago AnaIn AI & DataClinical TrialsInnovationLeaders
North America Leads January Biotech Funding Round with Nearly $2 Billion Raised, Oncology and Obesity Startups Dominate 1 year ago AnaIn Breaking NewsInvestmentsPartnershipsVenture Capital
Survey Reveals Clinicians Feel Ill-Prepared for Sex Differences in Disease Despite Frequent Observations 1 year ago AnaIn Industry ConferencesInvestmentsPeopleTop Stories
ALX Oncology Reveals Durable CD47 Blocker Responses in HER2-Positive Gastric Cancer at ASCO-GI 1 year ago AnaIn Pharma Industry UpdatesStartupsTop Stories
Oncolytics Biotech To Reveal New Pelareorep Efficacy and Safety Data at ASCO-GI for Anal and Pancreatic Cancers 1 year ago AnaIn BreakthroughsClinical TrialsTop Stories
Dogwood Therapeutics Begins Phase IIb Dosing of Halneuron® for Chemotherapy-Induced Neuropathic Pain 1 year ago AnaIn BreakthroughsClinical Trials
